Should men over the age of 65 years receive PSA screening? Argument against

Nature Clinical Practice Urology

Volumn 5, Issue 5, 2008, Pages 232-233

  Albertsen, Peter C ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN; PROSTATE SPECIFIC ANTIGEN;

AGING; ARTICLE; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SCREENING; CANCER SURVIVAL; CLINICAL TRIAL; COGNITIVE DEFECT; CONSERVATIVE TREATMENT; DIAGNOSTIC ACCURACY; GLEASON SCORE; HEALTH CARE POLICY; HOT FLUSH; HUMAN; LIFE EXPECTANCY; MOOD DISORDER; OSTEOPOROSIS; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATECTOMY; PUBLIC HEALTH; RISK BENEFIT ANALYSIS; SIDE EFFECT; TRANSRECTAL ULTRASONOGRAPHY; TREATMENT OUTCOME; TUMOR DIFFERENTIATION; WEIGHT GAIN;

AGED; HUMANS; LIFE EXPECTANCY; MALE; MASS SCREENING; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; TREATMENT FAILURE;

EID: 43449100700     PISSN: 17434270     EISSN: 17434289     Source Type: Journal    
DOI: 10.1038/ncpuro1079     Document Type: Article

References (11)

1. Walter LC et al. (2006) PSA screening among elderly mert with limited life expectancies. JAMA 296: 2336-2342
2. American Cancer Society Statistics for 2007 [http://www.cancer.org/ docroot/stt/stt_0.asp] (accessed 21 February 2008)
3. Johansson JE et al. (2004) Natural history of early, localized prostate cancer. JAMA 291: 2713-2719
4. Abertsen PC et al. (2005) 20-year outcomes following conservative management of clinically localized prostate cancer. JAMA 293 2095-2101
5. Albertsen PC et al. (2005) Prostate cancer and the Will Rogers phenomenon. J Natl Cancer Inst 97: 1248-1253
6. Bill-Axelson A et al. (2005) Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 352: 1977-1984
7. Draisma G et al. (2003) Lead times and overdetection due to prostate-specific antigen screening: Estimates from the European Randomized Study of Screening for Prostate Cancer. J Natl Cancer Inst 95: 868-878
8. Stanford JL et al. (2000) Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: The Prostate Cancer Outcomes Study. JAMA 283: 354-360
9. Hamilton AS et al. (2001) Health outcomes after external-beam radiation therapy for clinically localized prostate cancer: Results from the Prostate Cancer Outcomes Study. J Clin Oncol 19: 2517-2526
10. de Koning HJ et al. (2002) Large-scale randomized prostate cancer screening trials program performances in the European Randomized Screening for Prostate Cancer trial and trio Prostate Lung, Colorectal and Ovary cancer trial. Int J Cancer 97: 237-244
11. Gohagan JK et al. (2000) The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status. Control Clin Trials 21 (Suppl 6): 251S-272S